Library

Health Care

Athenex Inc (ATNX US)

Year: 2019

Athenex is US incorporated oncology pharmaceutical company with operations in China. It listed on the NASDAQ in June 2017. Between 22 October and 20 November 2019, short-seller Viceroy Research published ten research reports containing a large number of allegations including poor governance, dubious management, misleading press releases and deteriorating finances. It alleged that the company's main product, Oraxol, would not get regulatory approval. Viceroy's report failed to prompt any auditor or management resignations. However, in March 2020, it was disclosed that the FDA had not given Oraxol regulatory approval, prompting a collapse in the company's share price. As such, most of the allegations were not proven.

Last updated June 2022.

The information on this page has been compiled from publicly available sources. GMT Research Limited has not verified the information and does not warrant its accuracy. Any claims made or views expressed are not necessarily those of GMT Research Limited.

lock03 Read More

Back